Weifeng Liu

1.4k total citations · 1 hit paper
66 papers, 960 citations indexed

About

Weifeng Liu is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Cancer Research. According to data from OpenAlex, Weifeng Liu has authored 66 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 26 papers in Rheumatology and 18 papers in Cancer Research. Recurrent topics in Weifeng Liu's work include Sarcoma Diagnosis and Treatment (36 papers), Bone Tumor Diagnosis and Treatments (21 papers) and MicroRNA in disease regulation (9 papers). Weifeng Liu is often cited by papers focused on Sarcoma Diagnosis and Treatment (36 papers), Bone Tumor Diagnosis and Treatments (21 papers) and MicroRNA in disease regulation (9 papers). Weifeng Liu collaborates with scholars based in China, United States and United Kingdom. Weifeng Liu's co-authors include Xiaohui Niu, Hairong Xu, Yi Ding, Yongkun Yang, Hao Lin, Qing Zhang, Yuan Li, L H Gong, Yifan Wang and Zebin Lin and has published in prestigious journals such as Nano Letters, Nature Nanotechnology and Journal of Bone and Joint Surgery.

In The Last Decade

Weifeng Liu

53 papers receiving 945 citations

Hit Papers

The gut microbiota metabo... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis
    2021 186 citations Fan Deng, Bing-Cheng Zhao et al. Gut Microbes profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weifeng Liu China 15 469 386 309 203 190 66 960
Ming Xu China 16 467 1.0× 311 0.8× 235 0.8× 81 0.4× 94 0.5× 104 989
I. Gay United States 19 46 0.1× 235 0.6× 427 1.4× 133 0.7× 227 1.2× 27 1.1k
Jinrong Lin China 19 103 0.2× 109 0.3× 393 1.3× 175 0.9× 17 0.1× 61 989
Yasuo Yoshimura Japan 16 189 0.4× 152 0.4× 176 0.6× 17 0.1× 63 0.3× 52 833
J. C. Yao United States 13 99 0.2× 83 0.2× 179 0.6× 115 0.6× 20 0.1× 24 914
Toru Fujimoto Japan 13 142 0.3× 108 0.3× 233 0.8× 44 0.2× 15 0.1× 38 814
José Javier Martı́n de Llano Spain 18 44 0.1× 98 0.3× 232 0.8× 49 0.2× 82 0.4× 49 938
Marco Ponzetti Italy 15 69 0.1× 51 0.1× 412 1.3× 155 0.8× 21 0.1× 26 789
Toshiyuki Koizumi Japan 14 67 0.1× 44 0.1× 156 0.5× 47 0.2× 62 0.3× 49 582

Countries citing papers authored by Weifeng Liu

Since Specialization
Citations

This map shows the geographic impact of Weifeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Liu more than expected).

Fields of papers citing papers by Weifeng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Liu. The network helps show where Weifeng Liu may publish in the future.

Co-authorship network of co-authors of Weifeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Liu. A scholar is included among the top collaborators of Weifeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Liu. Weifeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Weifeng, Yong Cheng, Saishuai Dai, Zhiming Yuan, & Atilla İncecik. (2025). Wave energy harvesting performance of a novel dual-mode oscillating Buoy- parabolic oscillating water column (DOB-POWC) hybrid system. Renewable Energy. 248. 123157–123157. 3 indexed citations
3.
Cheng, Yong, Weifeng Liu, Saishuai Dai, Zhiming Yuan, & Atilla İncecik. (2024). Wave energy conversion by multi-mode exciting wave energy converters arrayed around a floating platform. Energy. 313. 133621–133621. 12 indexed citations
4.
Xiao, Cairong, Renxian Wang, Rumin Fu, et al.. (2024). Piezo-enhanced near infrared photocatalytic nanoheterojunction integrated injectable biopolymer hydrogel for anti-osteosarcoma and osteogenesis combination therapy. Bioactive Materials. 34. 381–400. 31 indexed citations
5.
Li, Yuan, et al.. (2024). Survival and functional outcomes after hemiarthroplasty in children with proximal tibial osteosarcoma. Journal of Orthopaedic Surgery and Research. 19(1). 619–619. 1 indexed citations
6.
Li, Zhuoyu, et al.. (2024). Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius. Journal of Orthopaedic Surgery and Research. 19(1). 607–607. 5 indexed citations
7.
Li, Zhuoyu, Weifeng Liu, Hao Lin, Qing Zhang, & Xiaohui Niu. (2024). The clinical outcomes and prognostic factors of dedifferentiated central chondrosarcoma in extremities. Journal of Orthopaedic Surgery and Research. 19(1). 621–621. 1 indexed citations
8.
Li, Zhuoyu, et al.. (2024). Is intercalary frozen autograft augmented with intramedullary cement and bridging plates fixation a durable reconstruction?. Journal of Orthopaedic Surgery and Research. 19(1). 740–740.
9.
10.
Liu, Weifeng, Huanqing Cheng, Zhen Huang, et al.. (2023). The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma. Molecular Oncology. 18(4). 939–955. 4 indexed citations
11.
Chen, Dafu, Ben Wan, Yuwen Luo, et al.. (2023). Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma. PeerJ. 11. e15814–e15814. 5 indexed citations
12.
Wang, Renxian, Dingding Wang, Jing‐Jun Nie, et al.. (2023). Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma. Cell Death Discovery. 9(1). 231–231. 7 indexed citations
13.
Lin, Zhengjun, Jian Zhou, Guoqing Li, et al.. (2023). Exosomal circRNAs in cancer: Implications for therapy resistance and biomarkers. Cancer Letters. 566. 216245–216245. 43 indexed citations
14.
15.
Gong, L H, Weifeng Liu, Xiaohui Niu, & Yi Ding. (2022). Two cases of spindle cell tumors with S100 and CD34 co-expression showing novel RAF1 fusions. Diagnostic Pathology. 17(1). 80–80. 4 indexed citations
16.
Deng, Fan, Bing-Cheng Zhao, Xiao Yang, et al.. (2021). The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis. Gut Microbes. 13(1). 1–21. 186 indexed citations breakdown →
17.
Liu, Weifeng, L H Gong, Marilyn M. Bui, et al.. (2020). Malignancy in giant cell tumor of bone in the extremities. Journal of bone oncology. 26. 100334–100334. 28 indexed citations
18.
Jin, Tao, et al.. (2018). How does iliosacral bone tumor resection without reconstruction affect the ipsilateral hip joint?. BMC Musculoskeletal Disorders. 19(1). 102–102. 13 indexed citations
19.
Jin, Tao, Weifeng Liu, Hairong Xu, Yuan Li, & Xiaohui Niu. (2017). Biomechanical Properties of Synthetic Mesh Reconstructed Glenohumeral Joint Capsule. Chinese Medical Journal. 130(14). 1743–1744.
20.
Ding, Yi, Xiaohui Niu, Weifeng Liu, et al.. (2011). Excision-alcoholization-replantation method in management of bone tumors. Zhonghua guke zazhi. 31(6). 652–657. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Xu Breakdown of academic impact, for papers by I. Gay Breakdown of academic impact, for papers by Jinrong Lin Breakdown of academic impact, for papers by Yasuo Yoshimura Breakdown of academic impact, for papers by J. C. Yao Breakdown of academic impact, for papers by Toru Fujimoto Breakdown of academic impact, for papers by José Javier Martı́n de Llano Breakdown of academic impact, for papers by Marco Ponzetti Breakdown of academic impact, for papers by Toshiyuki Koizumi
Rankless by CCL
2026